Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Use of positron emission tomography in the evaluation of diffuse intrinsic brainstem gliomas in children.

Rosenfeld A, Etzl M, Bandy D, Carpenteri D, Gieseking A, Dvorchik I, Kaplan A.

J Pediatr Hematol Oncol. 2011 Jul;33(5):369-73. doi: 10.1097/MPH.0b013e31820ad915.

PMID:
21602725
2.

Evaluation of 18F-FDG PET and MRI associations in pediatric diffuse intrinsic brain stem glioma: a report from the Pediatric Brain Tumor Consortium.

Zukotynski KA, Fahey FH, Kocak M, Alavi A, Wong TZ, Treves ST, Shulkin BL, Haas-Kogan DA, Geyer JR, Vajapeyam S, Boyett JM, Kun LE, Poussaint TY.

J Nucl Med. 2011 Feb;52(2):188-95. doi: 10.2967/jnumed.110.081463.

4.

Prediction of pathology and survival by FDG PET in gliomas.

Padma MV, Said S, Jacobs M, Hwang DR, Dunigan K, Satter M, Christian B, Ruppert J, Bernstein T, Kraus G, Mantil JC.

J Neurooncol. 2003 Sep;64(3):227-37.

PMID:
14558598
5.

Results of positron emission tomography guidance and reassessment of the utility of and indications for stereotactic biopsy in children with infiltrative brainstem tumors.

Pirotte BJ, Lubansu A, Massager N, Wikler D, Goldman S, Levivier M.

J Neurosurg. 2007 Nov;107(5 Suppl):392-9. doi: 10.3171/PED-07/11/392.

PMID:
18459902
6.

Direct comparison of 18F-FDG and 11C-methionine PET in suspected recurrence of glioma: sensitivity, inter-observer variability and prognostic value.

Van Laere K, Ceyssens S, Van Calenbergh F, de Groot T, Menten J, Flamen P, Bormans G, Mortelmans L.

Eur J Nucl Med Mol Imaging. 2005 Jan;32(1):39-51.

PMID:
15309329
7.
8.

Can multiparametric MRI and FDG-PET predict outcome in diffuse brainstem glioma? A report from a prospective phase-II study.

Goda JS, Dutta D, Raut N, Juvekar SL, Purandare N, Rangarajan V, Arora B, Gupta T, Kurkure P, Jalali R.

Pediatr Neurosurg. 2013;49(5):274-81. doi: 10.1159/000366167.

PMID:
25277867
9.

11C-methionine PET as a prognostic marker in patients with glioma: comparison with 18F-FDG PET.

Kim S, Chung JK, Im SH, Jeong JM, Lee DS, Kim DG, Jung HW, Lee MC.

Eur J Nucl Med Mol Imaging. 2005 Jan;32(1):52-9.

PMID:
15309332
10.

18F-FDG PET and MR imaging associations across a spectrum of pediatric brain tumors: a report from the pediatric brain tumor consortium.

Zukotynski K, Fahey F, Kocak M, Kun L, Boyett J, Fouladi M, Vajapeyam S, Treves T, Poussaint TY.

J Nucl Med. 2014 Sep;55(9):1473-80. doi: 10.2967/jnumed.114.139626.

11.

[Combined use of positron emission tomography with (18)F-fluorodeoxyglucose and (11)C-methionine for preoperative evaluation of gliomas].

Yamaguchi S, Terasaka S, Kobayashi H, Narita T, Hirata K, Shiga S, Usui R, Tanaka S, Kubota K, Murata J, Asaoka K.

No Shinkei Geka. 2010 Jul;38(7):621-8. Japanese.

PMID:
20628188
12.

¹⁸F-fluorodeoxyglucose and ¹¹C-methionine positron emission tomography in relation to methyl-guanine methyltransferase promoter methylation in high-grade gliomas.

Choi H, Bang JI, Cheon GJ, Kim YH, Park CK, Park SH, Kang KW, Chung JK, Kim EE, Lee DS.

Nucl Med Commun. 2015 Mar;36(3):211-8. doi: 10.1097/MNM.0000000000000236.

PMID:
25340951
13.

Comparison of (11)C-methionine, (11)C-choline, and (18)F-fluorodeoxyglucose-PET for distinguishing glioma recurrence from radiation necrosis.

Takenaka S, Asano Y, Shinoda J, Nomura Y, Yonezawa S, Miwa K, Yano H, Iwama T.

Neurol Med Chir (Tokyo). 2014;54(4):280-9.

14.

Preoperative evaluation of 54 gliomas by PET with fluorine-18-fluorodeoxyglucose and/or carbon-11-methionine.

Kaschten B, Stevenaert A, Sadzot B, Deprez M, Degueldre C, Del Fiore G, Luxen A, Reznik M.

J Nucl Med. 1998 May;39(5):778-85.

15.

Comparison of 18F-FDG and 11C-methionine for PET-guided stereotactic brain biopsy of gliomas.

Pirotte B, Goldman S, Massager N, David P, Wikler D, Vandesteene A, Salmon I, Brotchi J, Levivier M.

J Nucl Med. 2004 Aug;45(8):1293-8.

16.

Indolent dorsal midbrain tumor: new findings based on positron emission tomography.

Yamaguchi S, Terasaka S, Kobayashi H, Shiga T, Usui R, Hirata K, Kubota K, Murata J, Iwasaki Y.

J Neurosurg Pediatr. 2009 Apr;3(4):270-5. doi: 10.3171/2008.12.PEDS08323.

PMID:
19338404
17.

Imaging of adult brainstem gliomas.

Purohit B, Kamli AA, Kollias SS.

Eur J Radiol. 2015 Apr;84(4):709-20. doi: 10.1016/j.ejrad.2014.12.025. Review.

PMID:
25641008
18.

11C-methionine PET for grading and prognostication in gliomas: a comparison study with 18F-FDG PET and contrast enhancement on MRI.

Singhal T, Narayanan TK, Jacobs MP, Bal C, Mantil JC.

J Nucl Med. 2012 Nov;53(11):1709-15. doi: 10.2967/jnumed.111.102533.

19.

Paediatric brain-stem gliomas: MRI, FDG-PET and histological grading correlation.

Kwon JW, Kim IO, Cheon JE, Kim WS, Moon SG, Kim TJ, Chi JG, Wang KC, Chung JK, Yeon KM.

Pediatr Radiol. 2006 Sep;36(9):959-64.

PMID:
16847598
20.

Metabolic assessment of gliomas using 11C-methionine, [18F] fluorodeoxyglucose, and 11C-choline positron-emission tomography.

Kato T, Shinoda J, Nakayama N, Miwa K, Okumura A, Yano H, Yoshimura S, Maruyama T, Muragaki Y, Iwama T.

AJNR Am J Neuroradiol. 2008 Jun;29(6):1176-82. doi: 10.3174/ajnr.A1008.

Items per page

Supplemental Content

Support Center